Biosency has raised funds for further development

Biosency has completed a fundraising to develop a software for predictive diagnosis.

Biosency is a French MedTech company focused on changing the way clinicians and patients manage chronic obstructive pulmonary disease (COPD). The company provides innovative, connected and patient-focused remote monitoring solutions to analyze long-term trends of vital signs which are of critical importance to reduce readmission rates by adjusting medication.

Oaklins’ team in France acted as the exclusive advisor to Biosency.

Service

Funding, debt advisory & ECM

Parties

Talk to the deal team

Véronique Roth

Senior Advisor

Paris, France
Oaklins France

View profile Get in touch

Related deals

AMC Media Group has been acquired by Formedics

Healthcare | TMT

AMC Media Group has been acquired by Formedics

AMC Media Group, a health care professional (HCP) community platform that enables medical associations and key opinion leaders (KOLs) to drive engagement and monetization through their specialty digital properties, has been acquired by Formedics, an HCP community and engagement platform that is home to Physician's Weekly and OncWeekly.

Learn more

Bellefleur has been acquired by Domidep

Healthcare

Bellefleur has been acquired by Domidep

Belgian nursing home Bellefleur has been sold to Domidep, one of France’s largest private nursing home operators.

Learn more

Unitary Healthcare has been acquired by Axel Health

Private Equity | Healthcare | TMT

Unitary Healthcare has been acquired by Axel Health

Axel Health Oy, headquartered in Finland, has acquired the Finnish software company Unitary Healthcare Oy.

Learn more